Novotech report notes shift to adaptive designs in clinical trials
Covid-19 changed the global approach to prophylactic trials, many of which can benefit from adaptive designs, says the report.
Healthtech
Yonalink launches ICTN to position Israel as leader in clinical trial innovation
Reeves’ 2024 budget promises life sciences investment
Untapped opportunities: Fulfilling the promise of decentralized clinical trials
Signal: Lilly searches for new obesity drugs in partnership with Fauna Bio
Covid-19 pandemic accelerated digital transformation progress
Phesi’s free AI service seeks to resurrect at-risk trials and root out zombie studies
